Search research articles
Contact Us
Filters
Showing results (101-110 of 116) with videos related to
Page
of 12
Sort By:
Journal of Molecular Biology
|
February 23, 2013
Comprehensive interrogation of a minimalist synthetic CDR-H3 library and its ability to generate antibodies with therapeutic potential
Ciara M Mahon, Matthew A Lambert, Jacob Glanville, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 2, 2015
Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies
Sue Townsend, Brian J Fennell, James R Apgar, et al.
Alimentary Pharmacology & Therapeutics
|
January 10, 2009
The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up
C W Lees, A I Ali, A I Thompson, et al.
Journal of Molecular Biology
|
March 17, 2009
Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions
William J Finlay, Orla Cunningham, Matthew A Lambert, et al.
Nature Genetics
|
April 12, 2011
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A DePristo, Eric Banks, Ryan Poplin, et al.
Mabs
|
December 23, 2017
Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics
Lindsay B Avery, Jason Wade, Mengmeng Wang, et al.
Pharmacology Research & Perspectives
|
August 5, 2022
Characterization of TR-107, a novel chemical activator of the human mitochondrial protease ClpP
Emily M J Fennell, Lucas J Aponte-Collazo, Joshua D Wynn, et al.
ACS Chemical Biology
|
April 26, 2019
Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues
Paul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
Genome Biology
|
January 6, 2011
A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries
Sheila Fisher, Andrew Barry, Justin Abreu, et al.
Journal of Biotechnology
|
November 7, 2022
Impacts of fast production of afucosylated antibodies and Fc mutants in ExpiCHO-S™ for enhancing FcγRIIIa binding and NK cell activation
Xiaotian Zhong, Jennifer Schenk, Paul Sakorafas, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 116) with videos related to
Sort By:
Page
of 12
Journal of Molecular Biology
|
February 23, 2013
Comprehensive interrogation of a minimalist synthetic CDR-H3 library and its ability to generate antibodies with therapeutic potential
Ciara M Mahon, Matthew A Lambert, Jacob Glanville, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 2, 2015
Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies
Sue Townsend, Brian J Fennell, James R Apgar, et al.
Alimentary Pharmacology & Therapeutics
|
January 10, 2009
The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up
C W Lees, A I Ali, A I Thompson, et al.
Journal of Molecular Biology
|
March 17, 2009
Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions
William J Finlay, Orla Cunningham, Matthew A Lambert, et al.
Nature Genetics
|
April 12, 2011
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A DePristo, Eric Banks, Ryan Poplin, et al.
Mabs
|
December 23, 2017
Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics
Lindsay B Avery, Jason Wade, Mengmeng Wang, et al.
Pharmacology Research & Perspectives
|
August 5, 2022
Characterization of TR-107, a novel chemical activator of the human mitochondrial protease ClpP
Emily M J Fennell, Lucas J Aponte-Collazo, Joshua D Wynn, et al.
ACS Chemical Biology
|
April 26, 2019
Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues
Paul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
Genome Biology
|
January 6, 2011
A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries
Sheila Fisher, Andrew Barry, Justin Abreu, et al.
Journal of Biotechnology
|
November 7, 2022
Impacts of fast production of afucosylated antibodies and Fc mutants in ExpiCHO-S™ for enhancing FcγRIIIa binding and NK cell activation
Xiaotian Zhong, Jennifer Schenk, Paul Sakorafas, et al.
Page
of 12